The Stem Cell Engineering and Regenerative Medicine Research Group (SCERG) vision is to be a leader in cell and gene therapy and regenerative medicine, by translating pioneering research and development in stem cell, tissue and organ engineering and science to improve human health.
SCERG mission is to perform ground-breaking research translated into clinical applications, aiming to promote the development of novel Advanced Therapy Medicinal Products (ATMPs) to improve the quality of human health, with high technological impact in the healthcare sector. In addition to research, there is a strong emphasis on educating and training future scientists at PhD (Bioengineering: Cell Therapies and Regenerative Medicine) and MSc (Bioengineering: Regenerative and Precision Medicine) levels in cutting edge, interdisciplinary methods of science, engineering, and translational medicine.
SCERG aims at the development of cell production systems for the ex-vivo expansion of stem cells and/or their controlled differentiation into specific cell types, microtissues and organoids, as well as their integration with bioseparation and high resolution purification technologies, to generate the large numbers of specific and high quality stem/progenitor cell subsets needed for Regenerative and Precision Medicine settings. SCERG focuses on the development of personalized clinical and diagnostic applications and the development of platforms for the production of biomolecules, cells, tissues and organs for repair and replacement in the human body or for in vitro modelling, meeting the main challenges in Regenerative Medicine and the Biopharmaceutical industry.